Loratadine Tablet

Loratadine Tablets USP / BP / IP (10 mg)

Long-Acting, Non-Sedating Peripheral H1-Antihistamine

Healthy Life Pharma Private Limited, alongside our specialized global export and marketing division Healthy Inc, is a leading Indian manufacturer, CDMO partner, and wholesale exporter of advanced respiratory, allergy, and over-the-counter (OTC) public health therapeutics. We manufacture ultra-high-purity, chemically stable Loratadine Tablets within our state-of-the-art, WHO–GMP certified, high-capacity solid dosage manufacturing complexes.

Serving as a primary baseline therapeutic for the 24-hour stabilization of allergic symptoms, this essential product represents a high-velocity strategic export to national health ministries, retail pharmacy distribution chains, global humanitarian relief pipelines, and digital B2B marketplaces across Africa, the CIS region, LATAM, and South-East Asia.

Product Overview

This formulation operates as a “Peripheral Histamine H1-Receptor Antagonist.” It ensures immediate symptomatic relief and prevents localized allergic flare-ups by cutting off the cellular communication channels triggered by environmental allergens.

• Mechanism 1 (Selective H1-Receptor Competition): Loratadine is a long-acting tricyclic antihistamine that physically attaches to and competitively antagonizes peripheral histamine H1-receptors on vascular smooth muscle, endothelial cells, and respiratory tracts.

• Mechanism 2 (Blood-Brain Barrier Exclusion): Due to its unique chemical architecture and low lipophilicity, the drug is physically excluded from the central nervous system by active blood-brain barrier transport mechanisms. This completely eliminates the severe daytime drowsiness and psychomotor slowing common to first-generation molecules.

• Mechanism 3 (Allergic Cascade Downregulation): The stable receptor blockade chemically stops the histamine-induced accumulation of intracellular cyclic guanosine monophosphate ($cGMP$). This suppresses vascular permeability, prevents capillary leakage, and stops the tissue swelling that causes sneezing, watery eyes, and pruritus (itching).

Product Composition & Available Strengths

We supply Loratadine in the internationally recognized 10 mg therapeutic dosage configuration, optimized for maximum daily compliance and clean absorption kinetics.

Technical & Logistics Specifications

• HS Code: 3004.90.99 (Medicaments acting on the respiratory system / Antihistamines)

• CAS Number: 79794-75-5 (Loratadine)

• Dosage Form: Oral Solid Tablet (Compact, easy-to-swallow micro-tablets)

• Packaging Configurations:

  • OTC & Retail Packs: 10 / 14 / 20 / 30 Tablets per Blister Strip packed in high-barrier Alu-Alu (Cold-Form Foil) or clear PVC/PVDC strips.

  • Institutional Tenders: Bulk packs of 100 / 500 / 1000 Tablets per induction-sealed HDPE Bottle to maximize shipping cube efficiency and lower unit costs for national ministries. Our tropicalized packaging completely isolates the active core, guaranteeing a full 36-month shelf life in hot, humid Zone IVb export environments.

Advanced Manufacturing Integrity & Quality Controls

• High-Velocity Multi-Million Unit Output: To comfortably handle heavy institutional procurement volumes and seasonal tender spikes, we run high-speed rotary presses equipped with Automated Forced-Feeder Die Matrices and Online Weight-Verification Matrix Systems, physically ensuring absolute content uniformity across continuous multi-million unit production runs.

• Low Moisture Granulation Stability: Loratadine active material requires uniform matrix distribution to prevent compression capping. We process our blending and dry granulation cycles within Climate-Controlled ISO-Blocks with relative humidity held below 40%, preserving core physical stability.

• Validated Release and Dissolution Kinetics: Every single export production batch physically undergoes Automated In-Vitro Dissolution Profiling, chemically validating that our generic solid doses achieve rapid gastric disintegration (under 5 minutes), ensuring rapid systemic absorption and fast clinical intervention.

Primary Indications

• Respiratory & Allergy: Relief of nasal and non-nasal symptoms of Allergic Rhinitis (seasonal and perennial hay fever), including sneezing, nasal discharge (rhinorrhea), and nasal itching.

• Ophthalmology Adjuvant: Alleviation of allergic conjunctivitis symptoms, such as ocular itching and burning sensations.

• Dermatology: Symptomatic treatment and reduction of lesions associated with Chronic Idiopathic Urticaria (hives) and other allergic dermatological disorders.

Usage Instructions

• The 24-Hour Administration Window: Take one 10 mg tablet orally once daily with a full glass of water. It can be taken consistently either with or without food.

• The Non-Drowsiness Dosing Compliance: Unlike older antihistamines, Loratadine can be administered safely in the morning, physically allowing normal daily operations, driving, or heavy industrial machinery operation without risk of cognitive impairment.

• Hepatic Metabolism Pathway Note: Loratadine is heavily metabolized by the liver into its active metabolite, desloratadine, via the CYP3A4 and CYP2D6 enzyme pathways. For patients presenting with documented severe hepatic impairment, a modified initial dosing schedule of 10 mg every other day is clinically recommended.

Safety Warning: POTENT LONG-ACTING SECOND-GENERATION ANTIHISTAMINE. For Professional and OTC Supervision Guidelines Only. Allergy Skin Testing Disruption Note: Loratadine will chemically suppress peripheral histamine responses; therapy must be physically discontinued at least 48 to 72 hours prior to undergoing diagnostic allergy skin prick testing to prevent false-negative results. Pediatric Restrictions: Standard 10 mg solid tablets are calibrated for adult and pediatric populations aged greater than 6 years; utilize liquid drops or syrup formulations for younger age cohorts. Contraindications: Absolute contraindications in individuals presenting with documented hypersensitivity to loratadine or basic piperidine structure derivatives.

Global CDMO Services & Wholesale Tender Logistics

Healthy Life Pharma Private Limited and Healthy Inc provide comprehensive, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk private-label export supply for the entire Loratadine dosage spectrum. Because this molecule faces zero controlled-substance dual-licensing hurdles, our high-capacity lines can rapidly manufacture, release, and ship multi-container shipping loads. We prepare all legally required registration dossiers (WHO-GMP Certificate, Certificates of Pharmaceutical Product – COPP, Certificates of Analysis – COA, Stability Testing Matrix Sheets, and Complete CTD Format Dossier sets) for rapid entry registration.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Call: +91 7710003340

• Corporate Email: info@healthyinc.co.in